Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N
Department of Internal Medicine, National Hospital Organization, Utsunomiya National Hospital, Utsunomiya, Japan.
Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9. doi: 10.1055/s-2005-865680.
Impaired glucose tolerance (IGT) represents a stage of pre-diabetes and is a risk factor for future cardiovascular disease (CVD) which is a major cause of death in type 2 diabetes. The metabolic risk factors such as elevated blood pressure (elevated BP), abdominal obesity, dyslipidemia (elevated levels of total triglycerides [TG] and low levels of HDL cholesterol), and hyperglycemia precede the onset of the metabolic syndrome that increases the risk for CVD. This clustering is commonly associated with pre-diabetic hyperinsulinemia and it reflects peripheral insulin resistance. The present study documented that a visceral fat area (VFA) >/= 100 cm (2) can replace waist-to-hip ratios (WHR) associated with IGT or IFG/IGT as a critical risk for the development of the metabolic syndrome in Japanese middle-aged men.
A total of 575 middle-aged Japanese men with fasting plasma glucose levels of 6.1 - 6.9 mmol/l (impaired fasting glucose; IFG) were enrolled in the study. After a 75-g oral glucose tolerance test (OGTT), blood samples were collected 0 - 2 h later for determination of plasma glucose, insulin concentrations and other variables. Based on the results of an OGTT, the subjects were subgrouped into categories of glucose tolerance for further study.
Subjects with IGT or IFG/IGT had significantly higher levels of metabolic abnormalities such as high BMI, increased AUC glucose, elevated HbA1c, high VFA, elevated BP, and increased TG levels when compared to NGT (normal glucose tolerance) (p < 0.001). Compensatory hyper-secretion of insulin was seen in all pre-diabetic subjects, and was higher in IFG/IGT subjects (681 +/- 33 pmol . h/l) than NGT (480 +/- 22 pmol . h/l) (p < 0.01). The metabolic clustering including abnormal VFA, TG, HDL-C, and BP was strongly associated with the development of metabolic syndrome. Interestingly, VFA >/= 100 cm (2) adjusted for the Japanese correlates strongly with the development of the metabolic syndrome in preclinical IGT or IFG/IGT subjects, with odds ratios of 2.7 and higher.
VFA >/= 100 cm (2) strongly correlates with prediabetic IGT or IFG/IGT which is possibly associated with underlying insulin resistance, and is a critical risk factor linked to the development of metabolic syndrome in Japanese middle-aged subjects with IGT or IFG/IGT.
糖耐量受损(IGT)代表糖尿病前期阶段,是未来心血管疾病(CVD)的危险因素,而心血管疾病是2型糖尿病的主要死因。代谢风险因素如血压升高(BP升高)、腹型肥胖、血脂异常(总甘油三酯[TG]水平升高和高密度脂蛋白胆固醇水平降低)和高血糖先于代谢综合征的发生,代谢综合征会增加心血管疾病的风险。这种聚集通常与糖尿病前期高胰岛素血症相关,并且反映了外周胰岛素抵抗。本研究记录了内脏脂肪面积(VFA)≥100 cm²可以取代与IGT或空腹血糖受损/糖耐量受损(IFG/IGT)相关的腰臀比(WHR),作为日本中年男性发生代谢综合征的关键风险因素。
共有575名空腹血糖水平为6.1 - 6.9 mmol/l(空腹血糖受损;IFG)的日本中年男性参与本研究。在进行75克口服葡萄糖耐量试验(OGTT)后,0 - 2小时后采集血样以测定血糖、胰岛素浓度及其他变量。根据OGTT结果,将受试者分为不同糖耐量类别以进行进一步研究。
与糖耐量正常(NGT)相比,IGT或IFG/IGT受试者具有显著更高水平的代谢异常,如高体重指数(BMI)、葡萄糖曲线下面积(AUC葡萄糖)增加、糖化血红蛋白(HbA1c)升高、高VFA、血压升高和甘油三酯水平升高(p < 0.001)。所有糖尿病前期受试者均出现胰岛素代偿性高分泌,且IFG/IGT受试者(681±33 pmol·h/l)高于NGT受试者(480±22 pmol·h/l)(p < 0.01)。包括异常VFA、TG、高密度脂蛋白胆固醇(HDL-C)和血压在内的代谢聚集与代谢综合征的发生密切相关。有趣的是,根据日本人群相关因素调整后的VFA≥100 cm²与临床前期IGT或IFG/IGT受试者代谢综合征的发生密切相关,优势比为2.7及更高。
VFA≥100 cm²与糖尿病前期IGT或IFG/IGT密切相关,这可能与潜在的胰岛素抵抗有关,并且是日本IGT或IFG/IGT中年受试者发生代谢综合征的关键风险因素。